← Back to patent-cliff list
CAS 943320-50-1
3-iodo-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
Codes: HQP-1351-003
Application context (from source-drug indications)
Chronic myeloid leukaemiaOlverembatinib髓系白血病加速期OlverembatinibGastrointestinal stromal tumourOlverembatinibMyeloid leukaemiaOlverembatinibLymphocytic leukaemiaOlverembatinibAcute lymphoblastic leukaemiaOlverembatinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Olverembatinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
methyl 3-iodo-4-methylbenzoate→4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline→3-iodo-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide→HQP-1351-004→HQP-1351-005→HQP-1351
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.